ContractCollaboration Agreement • August 27th, 2019 • Adaptimmune Therapeutics PLC • Biological products, (no disgnostic substances) • New York
Certain confidential information contained in this document, marked by [***], has been omitted because it is both (i) not material and (ii) would be competitively harmful if publicly disclosed
